Molecular mechanisms of luteolin-7-o-glucoside-induced growth inhibition on human liver cancer cells: G2/m cell cycle arrest and caspase-independent apoptotic signaling pathways

61Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.

Abstract

Luteolin-7-O-glucoside (LUT7G), a flavone subclass of flavonoids, has been found to increase anti-oxidant and anti-inflammatory activity, as well as cytotoxic effects. However, the mechanism of how LUT7G induces apoptosis and regulates cell cycles remains poorly understood. In this study, we examined the effects of LUT7G on the growth inhibition of tumors, cell cycle arrest, induction of ROS generation, and the involved signaling pathway in human hepatocarcinoma HepG2 cells. The proliferation of HepG2 cells was decreased by LUT7G in a dose-dependent manner. The growth inhibition was due primarily to the G2/M phase arrest and ROS generation. Moreover, the phosphorylation of JNK was increased by LUT7G. These results suggest that the anti-proliferative effect of LUT7G on HepG2 is associated with G2/M phase cell cycle arrest by JNK activation. © 2013 by the The Korean Society for Biochemistry and Molecular Biology.

Cite

CITATION STYLE

APA

Hwang, Y. J., Lee, E. J., Kim, H. R., & Hwang, K. A. (2013). Molecular mechanisms of luteolin-7-o-glucoside-induced growth inhibition on human liver cancer cells: G2/m cell cycle arrest and caspase-independent apoptotic signaling pathways. BMB Reports, 46(12), 611–616. https://doi.org/10.5483/BMBRep.2013.46.12.133

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free